These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 21306209

  • 1. Efficacy and safety of ramelteon in Japanese adults with chronic insomnia: a randomized, double-blind, placebo-controlled study.
    Uchimura N, Ogawa A, Hamamura M, Hashimoto T, Nagata H, Uchiyama M.
    Expert Rev Neurother; 2011 Feb; 11(2):215-24. PubMed ID: 21306209
    [Abstract] [Full Text] [Related]

  • 2. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
    Mini LJ, Wang-Weigand S, Zhang J.
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):177-84. PubMed ID: 17996657
    [Abstract] [Full Text] [Related]

  • 3. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
    Roth T, Seiden D, Sainati S, Wang-Weigand S, Zhang J, Zee P.
    Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia.
    Zammit G, Erman M, Wang-Weigand S, Sainati S, Zhang J, Roth T.
    J Clin Sleep Med; 2007 Aug 15; 3(5):495-504. PubMed ID: 17803013
    [Abstract] [Full Text] [Related]

  • 5. The effects of ramelteon in a first-night model of transient insomnia.
    Zammit G, Schwartz H, Roth T, Wang-Weigand S, Sainati S, Zhang J.
    Sleep Med; 2009 Jan 15; 10(1):55-9. PubMed ID: 18691937
    [Abstract] [Full Text] [Related]

  • 6. Ramelteon: a novel approach in the treatment of insomnia.
    Reynoldson JN, Elliott E, Nelson LA.
    Ann Pharmacother; 2008 Sep 15; 42(9):1262-71. PubMed ID: 18648020
    [Abstract] [Full Text] [Related]

  • 7. An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.
    Erman M, Seiden D, Zammit G, Sainati S, Zhang J.
    Sleep Med; 2006 Jan 15; 7(1):17-24. PubMed ID: 16309958
    [Abstract] [Full Text] [Related]

  • 8. Use of a post-sleep questionnaire-interactive voice response system (PSQ-IVRS) to evaluate the subjective sleep effects of ramelteon in adults with chronic insomnia.
    Wang-Weigand S, Watissée M, Roth T.
    Sleep Med; 2011 Oct 15; 12(9):920-3. PubMed ID: 21925941
    [Abstract] [Full Text] [Related]

  • 9. A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance.
    McElroy SL, Winstanley EL, Martens B, Patel NC, Mori N, Moeller D, McCoy J, Keck PE.
    Int Clin Psychopharmacol; 2011 Jan 15; 26(1):48-53. PubMed ID: 20861739
    [Abstract] [Full Text] [Related]

  • 10. Ramelteon for the treatment of insomnia.
    Borja NL, Daniel KL.
    Clin Ther; 2006 Oct 15; 28(10):1540-55. PubMed ID: 17157111
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of ramelteon in a double-blind, placebo-controlled, crossover study in Japanese patients with chronic primary insomnia.
    Kohsaka M, Kanemura T, Taniguchi M, Kuwahara H, Mikami A, Kamikawa K, Uno H, Ogawa A, Murasaki M, Sugita Y.
    Expert Rev Neurother; 2011 Oct 15; 11(10):1389-97. PubMed ID: 21955196
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.
    Mayer G, Wang-Weigand S, Roth-Schechter B, Lehmann R, Staner C, Partinen M.
    Sleep; 2009 Mar 15; 32(3):351-60. PubMed ID: 19294955
    [Abstract] [Full Text] [Related]

  • 13. A polysomnography study of eszopiclone in elderly patients with insomnia.
    McCall WV, Erman M, Krystal AD, Rosenberg R, Scharf M, Zammit GK, Wessel T.
    Curr Med Res Opin; 2006 Sep 15; 22(9):1633-42. PubMed ID: 16968566
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial.
    Lydiard RB, Lankford DA, Seiden DJ, Landin R, Farber R, Walsh JK.
    J Clin Sleep Med; 2006 Jul 15; 2(3):309-15. PubMed ID: 17561543
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of indiplon in older adults with primary insomnia.
    Walsh JK, Moscovitch A, Burke J, Farber R, Roth T.
    Sleep Med; 2007 Nov 15; 8(7-8):753-9. PubMed ID: 17825616
    [Abstract] [Full Text] [Related]

  • 16. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW, Suess PE, Griffiths RR.
    Arch Gen Psychiatry; 2006 Oct 15; 63(10):1149-57. PubMed ID: 17015817
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of subjective efficacy and safety of ramelteon in Japanese subjects with chronic insomnia.
    Uchiyama M, Hamamura M, Kuwano T, Nishiyama H, Nagata H, Uchimura N.
    Sleep Med; 2011 Feb 15; 12(2):119-26. PubMed ID: 21256803
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T, Soubrane C, Titeux L, Walsh JK, Zoladult Study Group.
    Sleep Med; 2006 Aug 15; 7(5):397-406. PubMed ID: 16815744
    [Abstract] [Full Text] [Related]

  • 19. The Effect of Ramelteon on Heartburn Symptoms of Patients With Gastroesophageal Reflux Disease and Chronic Insomnia: A Pilot Study.
    Jha LK, Fass R, Gadam R, Maradey-Romero C, Nasrollah L, Hershcovici T, Quan SF, Dickman R.
    J Clin Gastroenterol; 2016 Feb 15; 50(2):e19-24. PubMed ID: 25887111
    [Abstract] [Full Text] [Related]

  • 20. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia.
    Roth T, Walsh JK, Krystal A, Wessel T, Roehrs TA.
    Sleep Med; 2005 Nov 15; 6(6):487-95. PubMed ID: 16230048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.